Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 934694, 8 pages
http://dx.doi.org/10.1155/2010/934694
Research Article

Characterization of Recombinant Dengue-2 Virus Derived from a Single Nucleotide Substitution in the 5′ Noncoding Region

1Department of Anatomy, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
2Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Center for Disease Control and Prevention, Fort Collins, CO 80522, USA

Received 25 May 2009; Revised 15 October 2009; Accepted 23 December 2009

Academic Editor: Shahid Jameel

Copyright © 2010 Vijittra Leardkamolkarn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Andino, G. E. Rieckhof, P. L. Achacoso, and D. Baltimore, “Poliovirus RNA synthesis utilizes an RNP complex formed around the 5-end of viral RNA,” The EMBO Journal, vol. 12, no. 9, pp. 3587–3598, 1993. View at Google Scholar · View at Scopus
  2. A. Cahour, A. Pletnev, M. Vazeille-Falcoz, L. Rosen, and C.-J. Lai, “Growth-restricted dengue virus mutant containing deletions in the 5 noncoding region of the RNA genome,” Virology, vol. 207, no. 1, pp. 68–76, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. R. M. del Angel, A. G. Papavassiliou, C. Fernandez-Tomas, S. J. Silverstein, and V. R. Racaniello, “Cell proteins bind to multiple sites within the 5 untranslated region of poliovirus RNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 21, pp. 8299–8303, 1989. View at Google Scholar · View at Scopus
  4. G. P. Pogue, X. Q. Cao, N. K. Singh, and H. L. Nakhasi, “5 sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins,” Journal of Virology, vol. 67, no. 12, pp. 7106–7117, 1993. View at Google Scholar · View at Scopus
  5. S. B. Stein, L. Zhang, and R. P. Roos, “Influence of Theiler's murine encephalomyelitis virus 5 untranslated region on translation and neurovirulence,” Journal of Virology, vol. 66, no. 7, pp. 4508–4517, 1992. View at Google Scholar · View at Scopus
  6. A. J. Macadam, S. R. Pollard, G. Ferguson et al., “The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity,” Virology, vol. 181, no. 2, pp. 451–458, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. V. Svitkin, T. V. Pestova, S. V. Maslova, and V. I. Agol, “Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains,” Virology, vol. 166, no. 2, pp. 394–404, 1988. View at Google Scholar · View at Scopus
  8. R. M. Kinney, G.-J. Chang, K. R. Tsuchiya et al., “Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein,” Journal of Virology, vol. 67, no. 3, pp. 1269–1277, 1993. View at Google Scholar
  9. R. J. Kuhn, D. E. Griffin, H. Zhang, H. G. M. Niesters, and J. H. Strauss, “Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA,” Journal of Virology, vol. 66, no. 12, pp. 7121–7127, 1992. View at Google Scholar · View at Scopus
  10. S. Butrapet, C. Y. H. Huang, D. J. Pierro, N. Bhamarapravati, D. J. Gubler, and R. M. Kinney, “Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5 noncoding region and nonstructural proteins 1 and 3,” Journal of Virology, vol. 74, no. 7, pp. 3011–3019, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Kinney, S. Butrapet, G.-J. J. Chang et al., “Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53,” Virology, vol. 230, no. 2, pp. 300–308, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. D. E. Alvarez, M. F. Lodeiro, C. V. Filomatori, S. Fucito, J. A. Mondotte, and A. V. Gamarnik, “Structural and functional analysis of dengue virus RNA,” Novartis Foundation Symposium, vol. 277, pp. 120–132, 2006. View at Google Scholar · View at Scopus
  13. C. V. Filomatori, M. F. Lodeiro, D. E. Alvarez, M. M. Samsa, L. Pietrasanta, and A. V. Gamarnik, “A 5 RNA element promotes dengue virus RNA synthesis on a circular genome,” Genes and Development, vol. 20, no. 16, pp. 2238–2249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Macadam, G. Ferguson, J. Burlison et al., “Correlation of RNA secondary structure and attenuation of sabin vaccine strains of poliovirus in tissue culture,” Virology, vol. 189, no. 2, pp. 415–422, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Bhamarapravati and Y. Sutee, “Live attenuated tetravalent dengue vaccine,” Vaccine, vol. 18, supplement 2, pp. 44–47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Bhamarapravati, S. Yorksan, and T. Chayaniyayothin, “Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers,” Bulletin of the World Health Organization, vol. 65, no. 2, pp. 189–195, 1987. View at Google Scholar · View at Scopus
  17. S. Yoksan, N. Bhamarapravati, and S. B. Halstead, “Dengue virus vaccine development: study on biological markers of uncloned dengue 1–4 viruses serially passaged in primary cells,” in Proceedings of the 4th Symposium on Arbovirus Research, T. D. George, Ed., pp. 35–38, Brisbane, Australia, May 1986.
  18. C. Y.-H. Huang, S. Butrapet, D. J. Pierro et al., “Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine,” Journal of Virology, vol. 74, no. 7, pp. 3020–3028, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Y.-H. Huang, S. Butrapet, K. R. Tsuchiya, N. Bhamarapravati, D. J. Gubler, and R. M. Kinney, “Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development,” Journal of Virology, vol. 77, no. 21, pp. 11436–11447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y.-H. Huang, S. J. Silengo, M. C. Whiteman, and R. M. Kinney, “Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus,” Journal of Virology, vol. 79, no. 12, pp. 7300–7310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Butrapet, R. M. Kinney, and C. Y.-H. Huang, “Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA,” Journal of Virological Methods, vol. 131, no. 1, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Zuker, “Mfold web server for nucleic acid folding and hybridization prediction,” Nucleic Acids Research, vol. 31, no. 13, pp. 3406–3415, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. C. Leitmeyer, D. W. Vaughn, D. M. Watts et al., “Dengue virus structural differences that correlate with pathogenesis,” Journal of Virology, vol. 73, no. 6, pp. 4738–4747, 1999. View at Google Scholar · View at Scopus
  24. W. Sirigulpanit, R. M. Kinney, and V. Leardkamolkarn, “Substitution or deletion mutations between nt 54 and 70 in the 5 non-coding region of dengue type 2 virus produce variable effects on virus viability,” Journal of General Virology, vol. 88, no. 6, pp. 1748–1752, 2007. View at Publisher · View at Google Scholar · View at Scopus